Phillip Kardis - Chimera Investment Chief Legal Officer ,Secretary
| CIM Stock | USD 13.54 0.09 0.66% |
Executive
Mr. Phillip J. Kardis II serves as Chief Legal Officer and Secretary of the company. Prior to becoming Chief Legal Officer, Mr. Kardis was a partner with the law firm of KL Gates LLP where he represented mortgage REITs and other companies and funds that acquire, originate, service and finance residential mortgage loans, mortgage servicing rights and mortgage backed securities, including the Company and Annaly Capital Management, Inc. Prior to joining KL Gates LLP in 2004, Mr. Kardis practiced corporate and securities law at several law firms. In addition, Mr. Kardis has held positions at the U.S. Department of Commerce, Rockwell International, the U.S. Senate Committee on the Budget and Analytic Services, Inc since 2015.
| Age | 58 |
| Tenure | 10 years |
| Address | 630 Fifth Avenue, New York, NY, United States, 10111 |
| Phone | 888 895 6557 |
| Web | https://www.chimerareit.com |
Phillip Kardis Latest Insider Activity
Tracking and analyzing the buying and selling activities of Phillip Kardis against Chimera Investment stock is an integral part of due diligence when investing in Chimera Investment. Phillip Kardis insider activity provides valuable insight into whether Chimera Investment is net buyers or sellers over its current business cycle. Note, Chimera Investment insiders must abide by specific rules, including filing SEC forms every time they buy or sell Chimera Investment'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Phillip Kardis over three weeks ago Disposition of 3623 shares by Phillip Kardis of Chimera Investment at 13.76 subject to Rule 16b-3 | ||
Phillip Kardis over two months ago Acquisition by Phillip Kardis of 137680 shares of Chimera Investment subject to Rule 16b-3 | ||
Phillip Kardis over a year ago Disposition of 5741 shares by Phillip Kardis of Chimera Investment at 4.36 subject to Rule 16b-3 |
Chimera Investment Management Efficiency
The company has Return on Asset of 0.0135 % which means that on every $100 spent on assets, it made $0.0135 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0693 %, implying that it generated $0.0693 on every 100 dollars invested. Chimera Investment's management efficiency ratios could be used to measure how well Chimera Investment manages its routine affairs as well as how well it operates its assets and liabilities. As of the 22nd of March 2025, Return On Tangible Assets is likely to drop to 0.01. In addition to that, Return On Capital Employed is likely to drop to 0.03. At this time, Chimera Investment's Total Assets are very stable compared to the past year. As of the 22nd of March 2025, Other Assets is likely to grow to about 13.8 B, while Non Current Assets Total are likely to drop about 980.1 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Timothy Johnson | Blackstone Mortgage Trust | 45 | |
| Timothy Hayes | Blackstone Mortgage Trust | 34 | |
| Sean Coon | Arbor Realty Trust | N/A | |
| Austin Pena | Blackstone Mortgage Trust | 39 | |
| Scott Mathias | Blackstone Mortgage Trust | 46 | |
| Fredric Weber | Arbor Realty Trust | 63 | |
| Jonathan Pollack | Blackstone Mortgage Trust | 47 | |
| Gail JD | Omega Healthcare Investors | 50 | |
| Dennis Reis | Arbor Realty Trust | 57 | |
| Kathleen Baldwin | Blackstone Mortgage Trust | N/A | |
| Marcin CFA | Blackstone Mortgage Trust | 49 | |
| Matthew CPA | Omega Healthcare Investors | 49 | |
| Kenneth Caplan | Blackstone Mortgage Trust | 52 | |
| Michael Ritz | Omega Healthcare Investors | 50 | |
| Robert IV | Blackstone Mortgage Trust | 46 | |
| Ken Fazio | Arbor Realty Trust | N/A | |
| Megan Krull | Omega Healthcare Investors | 47 | |
| JD BA | Arbor Realty Trust | 49 | |
| Vikas Gupta | Omega Healthcare Investors | 43 | |
| Kathleen McCarthyBaldwin | Blackstone Mortgage Trust | N/A | |
| Steven Insoft | Omega Healthcare Investors | 55 | |
Management Performance
| Return On Equity | 0.0693 | ||||
| Return On Asset | 0.0135 |
Chimera Investment Leadership Team
Elected by the shareholders, the Chimera Investment's board of directors comprises two types of representatives: Chimera Investment inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Chimera. The board's role is to monitor Chimera Investment's management team and ensure that shareholders' interests are well served. Chimera Investment's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Chimera Investment's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dan Thakkar, CoChief Officer | ||
| Miyun JD, Chief Secretary | ||
| Subramaniam Viswanathan, Chief and Principal Financial Officer | ||
| Teresa Bazemore, Independent Director | ||
| II Esq, CEO President | ||
| Mark Abrams, Independent Director | ||
| Kelley Kortman, Principal Accounting Officer | ||
| Debra Still, Independent Director | ||
| Matthew Lambiase, President, Chief Executive Officer, Director | ||
| John Reilly, Independent Director | ||
| Choudhary Yarlagadda, President, Chief Operating Officer, Director | ||
| Macdowell CFA, Chief Officer | ||
| Emily Mohr, Investor Officer | ||
| Gerard Creagh, Independent Director | ||
| Paul Donlin, Non-Executive Independent Chairman of the Board | ||
| Brian Reilly, Independent Director | ||
| Sandra Bell, Independent Director | ||
| Dennis Mahoney, Independent Director | ||
| Mohit Marria, Chief Executive Officer, Chief Investment Officer, Director | ||
| Kevin Chavers, Director | ||
| Robert Colligan, Chief Financial Officer | ||
| Phillip Kardis, Chief Legal Officer ,Secretary | ||
| Esq II, CEO President | ||
| Victor Falvo, Head Markets |
Chimera Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Chimera Investment a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0693 | ||||
| Return On Asset | 0.0135 | ||||
| Profit Margin | 0.63 % | ||||
| Operating Margin | 1.28 % | ||||
| Current Valuation | 11.04 B | ||||
| Shares Outstanding | 80.92 M | ||||
| Shares Owned By Insiders | 2.03 % | ||||
| Shares Owned By Institutions | 57.35 % | ||||
| Number Of Shares Shorted | 1.41 M | ||||
| Price To Earning | 10.17 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chimera Investment. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Chimera Stock, please use our How to Invest in Chimera Investment guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Mortgage Real Estate Investment Trusts (REITs) space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chimera Investment. If investors know Chimera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chimera Investment listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.8 | Dividend Share 1.42 | Earnings Share 1.1 | Revenue Per Share | Quarterly Revenue Growth 5.903 |
The market value of Chimera Investment is measured differently than its book value, which is the value of Chimera that is recorded on the company's balance sheet. Investors also form their own opinion of Chimera Investment's value that differs from its market value or its book value, called intrinsic value, which is Chimera Investment's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chimera Investment's market value can be influenced by many factors that don't directly affect Chimera Investment's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chimera Investment's value and its price as these two are different measures arrived at by different means. Investors typically determine if Chimera Investment is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chimera Investment's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.